189 related articles for article (PubMed ID: 36191006)
21. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
22. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
24. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract][Full Text] [Related]
25. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H; Cai Q; Godwin AK; Zhang R
Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
28. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
[TBL] [Abstract][Full Text] [Related]
29. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
[TBL] [Abstract][Full Text] [Related]
31. Smad7 maintains epithelial phenotype of ovarian cancer stem-like cells and supports tumor colonization by mesenchymal-epithelial transition.
Li Y; Gong W; Ma X; Sun X; Jiang H; Chen T
Mol Med Rep; 2015 Jan; 11(1):309-16. PubMed ID: 25333457
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
Jin M; Yang Z; Ye W; Xu H; Hua X
PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
[TBL] [Abstract][Full Text] [Related]
34. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
Lin M; Xia B; Qin L; Chen H; Lou G
DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
Liu J; Jin S; Wang R
Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
[TBL] [Abstract][Full Text] [Related]
36. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
38. Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.
Yu Z; Ouyang L
Hum Cell; 2022 Nov; 35(6):1824-1837. PubMed ID: 35964260
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]